MedicineNet.com
  MedicineNet home Health news and views Diseases and conditions Symptoms and signs Procedures and tests Medications Health and Living MedTerms medical dictionary  
Font Size
A
A
A


Medication Written by Pharmacists Reviewed by Doctors

Pharmacy Editor: Jay W. Marks, MD

GENERIC NAME: abatacept

BRAND NAME: Orencia

DRUG CLASS AND MECHANISM: Abatacept is an injectable, synthetic (man-made) protein produced by recombinant DNA technology that is used for treating rheumatoid arthritis.

The immune system is responsible for protecting the body against foreign invaders, for example, infectious agents such as bacteria. In patients with rheumatoid arthritis, however, the immune system attacks and destroys normal tissue in and around the joints, causing pain, inflammation and damage to bone and cartilage.

T-lymphocytes are important cells of the immune system. Patients with rheumatoid arthritis have increased numbers of T-lymphocytes within the joints that are inflamed. The T-lymphocytes are “activated,” that is, they multiply and release chemicals that promote the destruction of tissues surrounding the joints and cause the signs and symptoms of rheumatoid arthritis.

Abatacept acts like an antibody and attaches to a protein on the surface of T-lymphocytes. By attaching to the protein, abatacept prevents the activation of the T-lymphocytes and blocks both the production of new T-lymphocytes and the production of the chemicals that destroy tissue and cause the symptoms and signs of arthritis. Abatacept slows the damage to bones and cartilage and relieves the symptoms and signs of arthritis. Abatacept was approved by the FDA in December, 2005.

PRESCRIPTION: Yes

GENERIC AVAILABLE: No

PREPARATIONS: Powder for Injection: 250 mg

STORAGE: Refrigerate between 2-8°C (36-46°F).

PRESCRIBED FOR: Abatacept is used alone or in combination with other drugs for the treatment of adult patients with moderate to severe rheumatoid arthritis who have not adequately responded to one or more different disease-modifying drugs (i.e., drugs that slow the destruction of joints). Abatacept reduces the signs and symptoms of arthritis, slows the progression of damage to the joints, and improves the physical function of patients. Abatacept should not be combined with the disease-modifying TNF antagonists (e.g., Enbrel, Humira and Remicade).

DOSING: Abatacept is infused over 30 minutes. The initial dose of abatacept is followed by additional doses two and four weeks after the first infusion with further doses every 4 weeks thereafter. Patients weighing < 60 kg should receive a 500 mg dose, weighing 60-100 kg a 750 mg dose and weighing >100 kg a 1000 mg dose.

DRUG INTERACTIONS: Combining abatacept with TNF antagonists (e.g., Enbrel, Humira and Remicade) increases the occurrence of infections and provides no additional relief of symptoms.

PREGNANCY: Abatacept has not been adequately evaluated in pregnant women.

NURSING MOTHERS: Abatacept has not been adequately evaluated in women who are nursing.

SIDE EFFECTS: The most common side effects include headache, upper respiratory tract infections and nausea. Because abatacept depresses the immune system it reduces the body's ability to fight infection. Therefore existing infections may worsen or new ones may develop. Patients may also experience infusion related reactions such as dizziness, headache, hypotension or hypertension, nausea, wheezing, rash, nausea and shortness of breath. The most serious side effects are infections and cancer.






Printer-Friendly Format  |  Email to a Friend


space Related health and medical articles From the Doctors at MedicineNet.com MedicineNet Doctors recommend space
space
MedicineNet Doctors Recommend
  • Rheumatoid Arthritis - Learn more about rheumatoid arthritis, an autoimmune disease that causes chronic joint inflammation, which has symptoms that include stiffness, fever, muscle and joint aches, loss of appetite, and fatigue. Treatment of rheumatoid arthritis incorporates the use of first-line drugs (aspirin and corticosteroids for pain and inflammation) and second-line drugs (methotrexate and hydroxychloroquine to prevent joint destruction and promote remission). Source:MedicineNet
  • IV Drug Infusion FAQs - Learn what to expect during an intravenous (IV) drug infusion of medicine and avoid the confusion of what to expect. Information on what to bring, questions to ask the staff, and follow-up are included. Source:MedicineNet
  • Read 10 more abatacept related articles ...
Latest Medical News
space

Back to Medications Index


Last Editorial Review: 2/9/2006





Topics Related to abatacept, Orencia

abatacept
RSS FeedSpecialty RSS       Add to My Yahoo! What is this?

Joint CampJoint Camp
Today, Baby Boomers go to "joint" camp to prepare for hip and knee replacement surgery. See more WebMD Videos »

Arthritis

Get the latest treatment options











Health categories:

News & Views | Diseases & Conditions | Symptoms & Signs | Procedures & Tests | Medications | Health & Living | Medical Dictionary

Popular health centers:

Allergies | Arthritis | Cancer | Diabetes | Digestion | Healthy Kids | Heart | Men's Health | Mental Health | Women's Health | More...

Publications:

ePublications (PDFs) | XML News via RSS | Audio Podcasts | Email Newsletters

MedicineNet.com:

About Us | Privacy Policy | Search Help | Site Map | WebMD® | Medscape® | eMedicine® | eMedicineHealth® | RxList®

HON Code We comply with the HONcode standard for health trust worthy information:
verify here.

©1996-2008 MedicineNet, Inc. All rights reserved. Notices and Legal Disclaimer.
MedicineNet does not provide medical advice, diagnosis or treatment. See additional information.